229d

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="229d" size="350" color="white" frame="true" align="right" spinBox="true" caption="229d" /> '''DNA ANALOG OF YEAST TRANSFER RNA PHE ANTICOD...)
Line 4: Line 4:
==Overview==
==Overview==
-
Design of biologically active DNA analogues of the yeast tRNA(Phe), anticodon domain, tDNAPheAC, required the introduction of a, d(m5C)-dependent, Mg(2+)-induced structural transition and the d(m1G), disruption of an intra-loop dC.dG base pair. The modifications were, introduced at residues corresponding to m5C-40 and wybutosine-37 in, tRNA(Phe). Modified tDNAPheAC inhibited translation by 50% at a, tDNAPheAC:ribosome ratio of 8:1. The molecule's structure has been, determined by NMR spectroscopy and restrained molecular dynamics with an, overall r.m.s.d. of 2.8 A and 1.7 A in the stem, and is similar to the, tRNA(Phe) anticodon domain in conformation and dimensions. The tDNAPheAC, structure may provide a guide for the design of translation inhibitors as, potential therapeutic agents.
+
Design of biologically active DNA analogues of the yeast tRNA(Phe) anticodon domain, tDNAPheAC, required the introduction of a d(m5C)-dependent, Mg(2+)-induced structural transition and the d(m1G) disruption of an intra-loop dC.dG base pair. The modifications were introduced at residues corresponding to m5C-40 and wybutosine-37 in tRNA(Phe). Modified tDNAPheAC inhibited translation by 50% at a tDNAPheAC:ribosome ratio of 8:1. The molecule's structure has been determined by NMR spectroscopy and restrained molecular dynamics with an overall r.m.s.d. of 2.8 A and 1.7 A in the stem, and is similar to the tRNA(Phe) anticodon domain in conformation and dimensions. The tDNAPheAC structure may provide a guide for the design of translation inhibitors as potential therapeutic agents.
==About this Structure==
==About this Structure==
Line 12: Line 12:
Design, biological activity and NMR-solution structure of a DNA analogue of yeast tRNA(Phe) anticodon domain., Basti MM, Stuart JW, Lam AT, Guenther R, Agris PF, Nat Struct Biol. 1996 Jan;3(1):38-44. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=8548453 8548453]
Design, biological activity and NMR-solution structure of a DNA analogue of yeast tRNA(Phe) anticodon domain., Basti MM, Stuart JW, Lam AT, Guenther R, Agris PF, Nat Struct Biol. 1996 Jan;3(1):38-44. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=8548453 8548453]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Agris, P.F.]]
+
[[Category: Agris, P F.]]
-
[[Category: Basti, M.M.]]
+
[[Category: Basti, M M.]]
[[Category: Guenther, R.]]
[[Category: Guenther, R.]]
-
[[Category: Lam, A.T.]]
+
[[Category: Lam, A T.]]
-
[[Category: Stuart, J.W.]]
+
[[Category: Stuart, J W.]]
[[Category: anticodon]]
[[Category: anticodon]]
[[Category: dna]]
[[Category: dna]]
Line 22: Line 22:
[[Category: transfer rna]]
[[Category: transfer rna]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jan 29 17:48:06 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:21:18 2008''

Revision as of 14:21, 21 February 2008


229d

Drag the structure with the mouse to rotate

DNA ANALOG OF YEAST TRANSFER RNA PHE ANTICODON DOMAIN WITH MODIFIED BASES 5-METHYL CYTOSINE AND 1-METHYL GUANINE

Overview

Design of biologically active DNA analogues of the yeast tRNA(Phe) anticodon domain, tDNAPheAC, required the introduction of a d(m5C)-dependent, Mg(2+)-induced structural transition and the d(m1G) disruption of an intra-loop dC.dG base pair. The modifications were introduced at residues corresponding to m5C-40 and wybutosine-37 in tRNA(Phe). Modified tDNAPheAC inhibited translation by 50% at a tDNAPheAC:ribosome ratio of 8:1. The molecule's structure has been determined by NMR spectroscopy and restrained molecular dynamics with an overall r.m.s.d. of 2.8 A and 1.7 A in the stem, and is similar to the tRNA(Phe) anticodon domain in conformation and dimensions. The tDNAPheAC structure may provide a guide for the design of translation inhibitors as potential therapeutic agents.

About this Structure

229D is a Protein complex structure of sequences from [1]. Full crystallographic information is available from OCA.

Reference

Design, biological activity and NMR-solution structure of a DNA analogue of yeast tRNA(Phe) anticodon domain., Basti MM, Stuart JW, Lam AT, Guenther R, Agris PF, Nat Struct Biol. 1996 Jan;3(1):38-44. PMID:8548453

Page seeded by OCA on Thu Feb 21 16:21:18 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools